ICU vs STRO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ICU

60.7
AI Score
VS
ICU Wins

STRO

36.9
AI Score

Investment Advisor Scores

ICU

61score
Recommendation
BUY

STRO

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICU STRO Winner
Revenue 1.11M 24.36M STRO
Net Income -7.25M -77.02M ICU
Net Margin -653.2% -316.1% STRO
Operating Income -7.39M -59.54M ICU
ROE -168.8% 74.5% STRO
ROA -83.8% -39.6% STRO
Total Assets 8.65M 194.46M STRO
Cash 6.96M 54.34M STRO
Current Ratio 1.89 3.32 STRO

Relative Price Performance (Last 90 Days)

ICU 1M: -9.8% · 3M: +11.0% STRO 1M: -20.8% · 3M: -36.3%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $3.03

STRO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.7%), weak momentum, RSI 25

RSI (14): 25.3 · Price: $16.86

Fundamentals Snapshot

Metric ICU STRO
Market Cap
Forward P/E -1.3 -2.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.8% -0.8%
Gross Margin 0.9% -2.2%
Operating Margin -6.2% -3.0%
EPS -1.89 -16.91
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.